Welcome to our dedicated page for Conmed news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed stock.
CONMED Corporation (NYSE: CNMD) is a medical equipment company in the surgical and medical instrument manufacturing industry. Its products are used in sports medicine procedures and general surgeries across specialties such as orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. The CONMED news feed on this page aggregates company-issued press releases and other coverage related to its operations, strategy and financial performance.
Recent news highlights include updates on portfolio optimization, such as CONMED’s announced intent to exit its gastroenterology product lines and to conclude a distribution agreement for a biliary stent product. The company has linked this decision to a focus on core markets in minimally invasive, robotic and laparoscopic surgery, smoke evacuation, and orthopedic soft tissue repair. News items also cover quarterly and year-to-date financial results, where CONMED reports net sales by orthopedic and general surgery categories, and by single-use and capital products, along with domestic and international growth metrics.
Investors and observers can also follow governance and leadership developments through this news stream. CONMED has issued releases about changes to its Board of Directors, including the appointment of a new independent director and the resignation of another director to take a leadership role at another organization. The company has also announced a planned transition of its Chief Financial Officer, describing the timing and advisory period associated with that change.
Other news topics include capital allocation decisions, such as the declaration of a quarterly cash dividend and the subsequent authorization of a share repurchase program with suspension of the dividend, as well as participation in healthcare investment conferences where CONMED presents investor materials and financial guidance. Users interested in CNMD can use this page to review these types of announcements over time and to see how the company describes its strategy, operations and financial outlook.
CONMED Corporation (NYSE: CNMD) announced that Todd W. Garner, Executive Vice President and CFO, will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 12:25 p.m. ET. A live webcast of the presentation will be available in the ‘Investors’ section on the company’s website, with a replay accessible post-event. CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties including orthopedics and neurosurgery. For further details, visit www.conmed.com.
CONMED Corporation (NYSE: CNMD) reported Q3 2020 financial results with sales of $237.8 million, an increase of 1.8% year-over-year. Domestic revenues grew by 4.7%, while international revenues fell by 1.7%. GAAP diluted EPS was $0.23, unchanged from Q3 2019, but adjusted diluted EPS rose to $0.88 from $0.62. The company noted ongoing operational challenges due to COVID-19 but expressed confidence in achieving future growth. However, financial guidance remains unavailable due to pandemic uncertainties.
CONMED Corporation (NYSE: CNMD) will report its financial results for Q3 2020 after market close on October 28, 2020. A conference call will be held at 4:30 p.m. ET for discussions regarding the results. Interested parties can access the call by dialing 1-844-889-7792 (domestic) or +1-661-378-9936 (international) using passcode 2498889. The call will also be webcast on the company’s website. Forward-looking statements will be included, highlighting potential risks and uncertainties affecting future performance.